Dr. Thomas Grader-Beck, MD

Dr. Grader-Beck practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Grader-Beck's NPI, 1336163500, was assigned on July 27, 2006. Dr. Grader-Beck holds Maryland license D64654.

Dr. Grader-Beck's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Grader-Beck's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Grader-Beck is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grader-Beck practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Grader-Beck's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Grader-Beck is licensed in Maryland.

CMS data shows 531 Medicare services from Dr. Grader-Beck across 4 procedure codes in 2024, for 243 Medicare patients. Medicare paid $31,625 for them.

CMS counts 243 Medicare patients who saw Dr. Grader-Beck in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have arthritis, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grader-Beck's median patient age at 67, with 88% women.

In 2024, Dr. Grader-Beck wrote 833 Medicare Part D claims for 120 patients. 75% of them were for generic drugs. CMS names the drug for 659 of them, across 16 drugs with 11 or more claims each, at $945,776 in total drug cost. In 2023, CMS named 636 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Grader-Beck for performance year 2024, reported as part of a group. CMS lists Dr. Grader-Beck as offering telehealth.

Dmand AI links 5 papers to Dr. Grader-Beck, published from 2011 to 2023. The most frequent topics are Patient Reported Outcome Measures and Arthritis, Psoriatic. Dr. Grader-Beck's most frequent co-authors are Bruce S. Bochner, MD, Francesco Boin, MD and Erin Chew.

Dmand AI links Dr. Grader-Beck to 1 clinical trial. Conditions studied include Sjogren's Syndrome and Xerostomia. Open Payments lists research payments to Dr. Grader-Beck that name 1 trial.

CMS Open Payments shows 47 general payments to Dr. Grader-Beck from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Novartis Pharmaceuticals Corporation paid the most, $54,012. It also lists 5 research payments totaling $70,763 from 2016 to 2025, naming 1 clinical trial.